Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Contemporary Clinical Trials|January 22, 2022
Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf studyN Reimer, R Hafke, M Wrensch, et al.
Nuklearmedizin. Nuclear Medicine|August 10, 2013
Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter readingC Furth, A S Erdrich, I G Steffen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18C-A Voltin, H Goergen, C Baues, et al.
International Journal of Physical Medicine & Rehabilitation|August 25, 2020
Effectiveness of Semantic Encoding Strategy Training after Traumatic Brain Injury is Correlated with Frontal Brain Activation ChangeRebecca J Lepping, William M Brooks, Brenda A Kirchhoff, et al.
Nuklearmedizin. Nuclear Medicine|February 4, 2010
Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studiesMarkus Dietlein, S M Börner, T Fischer, et al.
Brain, Behavior, and Immunity|April 23, 2025
Recombinant human DNase treatment mitigates extracellular trap mediated damage and improves long-term recovery after spinal cord injury in male miceShelby K Reid, Miranda E Leal-Garcia, Ashley V Tran, et al.
Journal of Neuroinflammation|December 25, 2021
Spleen tyrosine kinase facilitates neutrophil activation and worsens long-term neurologic deficits after spinal cord injuryDylan A McCreedy, Clare L Abram, Yongmei Hu, et al.
Circulation|December 16, 1998
Effects of a monoclonal antibody to P-selectin on recovery of neonatal lamb hearts after cold cardioplegic ischemiaM Nagashima, T Shin'oka, G Nollert, et al.
Nuklearmedizin. Nuclear Medicine|September 22, 2015
Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphomaC Kobe, G Kuhnert, H Haverkamp, et al.
Lung Cancer (Amsterdam, Netherlands)|April 6, 2013
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinibM Bos, M Gardizi, H U Schildhaus, et al.
Pageof 13